BIOEAST, a growing innovator in IVD raw material solutions and POCT solutions, recently concluded its successful participation at the American Association for Clinical Chemistry's (AACC) annual event, now known as ADLM 2023. The company is humbled and grateful for the tremendous support from all the remarkable friends and clients who visited their booth during the event.

With a booth that captured attention and interest, BIOEAST showcased its cutting-edge IVD raw material solutions and POCT solutions, leaving a lasting impression on its American clients. The presence and support of attendees played a pivotal role in contributing to the company's success at AACC 2023.

"We extend our heartfelt gratitude to everyone who took the time to visit our booth at ADLM 2023," said a spokesperson from BIOEAST. "Your support and engagement have been instrumental in our achievements at the event. We are genuinely excited about the potential for future collaborations and partnerships that can bring about mutual benefits."

Anticipating the road ahead, BIOEAST is already gearing up for the next edition of the event. The company warmly invites all to mark their calendars for ADLM 2024, scheduled to take place in Chicago. With the momentum garnered from this year's success, BIOEAST is eager to continue making strides in the IVD and POCT sectors, offering innovative solutions that make a meaningful impact on the healthcare industry.

For the latest updates and information about BIOEAST's progress in IVD raw material solutions and POCT solutions, stay connected with their official website and social media platforms. The company's commitment to delivering excellence and dedication to advancing healthcare remain steadfast, as showcased by its successful participation at ADLM 2023.

Click the pic to BIOEAST's Youtube Channel